Skip to main content
. 2021 Mar 25;9:628128. doi: 10.3389/fcell.2021.628128

FIGURE 3.

FIGURE 3

Concentrations of galectin-9 (Gal-9) in peripheral blood mononuclear cells (PBMCs). PBMCs derived from patients with idiopathic inflammatory myopathies and healthy controls (HCs). (A) Gal-9 levels in PBMCs derived from patients with dermatomyositis (DM), patients with immune-mediated necrotizing myopathy (IMNM), and HCs. (B,C) mRNA expression of type-I interferon-inducible gene myxovirus resistance 1 (MX1) (B) and interferon induced with helicase C domain 1 (IFIH1) (C) in patients with DM, patients with IMNM, and HCs. (D,E) Correlations between Gal-9 and MX1 (D) and IFIH1 (E) mRNA expression levels in patients with DM. Horizontal bars indicate mean ± standard deviation.